These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 19128786)

  • 1. Glimpses of the epigenetic landscape.
    Shen X; Orkin SH
    Cell Stem Cell; 2009 Jan; 4(1):1-2. PubMed ID: 19128786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation.
    Cui K; Zang C; Roh TY; Schones DE; Childs RW; Peng W; Zhao K
    Cell Stem Cell; 2009 Jan; 4(1):80-93. PubMed ID: 19128795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An epigenetic profile of early T-cell development from multipotent progenitors to committed T-cell descendants.
    Vigano MA; Ivanek R; Balwierz P; Berninger P; van Nimwegen E; Karjalainen K; Rolink A
    Eur J Immunol; 2014 Apr; 44(4):1181-93. PubMed ID: 24374622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromatin modifications in hematopoietic multipotent and committed progenitors are independent of gene subnuclear positioning relative to repressive compartments.
    Guillemin C; Maleszewska M; Guais A; Maës J; Rouyez MC; Yacia A; Fichelson S; Goodhardt M; Francastel C
    Stem Cells; 2009 Jan; 27(1):108-15. PubMed ID: 18974210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional, epigenetic and retroviral signatures identify regulatory regions involved in hematopoietic lineage commitment.
    Romano O; Peano C; Tagliazucchi GM; Petiti L; Poletti V; Cocchiarella F; Rizzi E; Severgnini M; Cavazza A; Rossi C; Pagliaro P; Ambrosi A; Ferrari G; Bicciato S; De Bellis G; Mavilio F; Miccio A
    Sci Rep; 2016 Apr; 6():24724. PubMed ID: 27095295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NA-Seq: a discovery tool for the analysis of chromatin structure and dynamics during differentiation.
    Gargiulo G; Levy S; Bucci G; Romanenghi M; Fornasari L; Beeson KY; Goldberg SM; Cesaroni M; Ballarini M; Santoro F; Bezman N; Frigè G; Gregory PD; Holmes MC; Strausberg RL; Pelicci PG; Urnov FD; Minucci S
    Dev Cell; 2009 Mar; 16(3):466-81. PubMed ID: 19289091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA Methylation Dynamics of Human Hematopoietic Stem Cell Differentiation.
    Farlik M; Halbritter F; Müller F; Choudry FA; Ebert P; Klughammer J; Farrow S; Santoro A; Ciaurro V; Mathur A; Uppal R; Stunnenberg HG; Ouwehand WH; Laurenti E; Lengauer T; Frontini M; Bock C
    Cell Stem Cell; 2016 Dec; 19(6):808-822. PubMed ID: 27867036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic changes of the epigenetic landscape during cellular differentiation.
    Dambacher S; de Almeida GP; Schotta G
    Epigenomics; 2013 Dec; 5(6):701-13. PubMed ID: 24283883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of an active tissue-specific chromatin domain initiated by epigenetic marking at the embryonic stem cell stage.
    Szutorisz H; Canzonetta C; Georgiou A; Chow CM; Tora L; Dillon N
    Mol Cell Biol; 2005 Mar; 25(5):1804-20. PubMed ID: 15713636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation is a guardian of stem cell self-renewal and multipotency.
    Gereige LM; Mikkola HK
    Nat Genet; 2009 Nov; 41(11):1164-6. PubMed ID: 19862008
    [No Abstract]   [Full Text] [Related]  

  • 11. Epigenetic regulation of cardiovascular differentiation.
    Ohtani K; Dimmeler S
    Cardiovasc Res; 2011 Jun; 90(3):404-12. PubMed ID: 21372004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic plasticity of chromatin in embryonic and hematopoietic stem/progenitor cells: therapeutic potential of cell reprogramming.
    Zardo G; Cimino G; Nervi C
    Leukemia; 2008 Aug; 22(8):1503-18. PubMed ID: 18548105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic regulation in neural stem cell differentiation.
    Juliandi B; Abematsu M; Nakashima K
    Dev Growth Differ; 2010 Aug; 52(6):493-504. PubMed ID: 20608952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multitalented E2A: a new role in lymphoid-lineage priming.
    Kondo M
    Immunity; 2008 Aug; 29(2):169-70. PubMed ID: 18701077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A minimal ubiquitous chromatin opening element (UCOE) effectively prevents silencing of juxtaposed heterologous promoters by epigenetic remodeling in multipotent and pluripotent stem cells.
    Müller-Kuller U; Ackermann M; Kolodziej S; Brendel C; Fritsch J; Lachmann N; Kunkel H; Lausen J; Schambach A; Moritz T; Grez M
    Nucleic Acids Res; 2015 Feb; 43(3):1577-92. PubMed ID: 25605798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of histone modifications across mammalian genomes: implications for 'epigenetic' marking.
    Lee BM; Mahadevan LC
    J Cell Biochem; 2009 Sep; 108(1):22-34. PubMed ID: 19623574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone acetylation and chromatin signature in stem cell identity and cancer.
    Shukla V; Vaissière T; Herceg Z
    Mutat Res; 2008 Jan; 637(1-2):1-15. PubMed ID: 17850830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide epigenetic analysis of human pluripotent stem cells by ChIP and ChIP-Seq.
    Hitchler MJ; Rice JC
    Methods Mol Biol; 2011; 767():253-67. PubMed ID: 21822881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional regulation by histone modifications: towards a theory of chromatin re-organization during stem cell differentiation.
    Binder H; Steiner L; Przybilla J; Rohlf T; Prohaska S; Galle J
    Phys Biol; 2013 Apr; 10(2):026006. PubMed ID: 23481318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epigenetic landscape of T-cell acute lymphoblastic leukemia.
    Van der Meulen J; Van Roy N; Van Vlierberghe P; Speleman F
    Int J Biochem Cell Biol; 2014 Aug; 53():547-57. PubMed ID: 24786297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.